AI Engines For more Details: Perplexity Kagi Labs You
Antineoplastic Activity: Temozolomide is an alkylating agent that works by damaging the DNA of cancer cells, leading to their death. It is effective in slowing down or stopping the growth of cancer cells, particularly in brain tumors.
Brain Tumors: Temozolomide is commonly used in the treatment of glioblastoma multiforme (GBM), which is the most aggressive type of primary brain tumor. It is also used for the treatment of anaplastic astrocytoma, another type of brain tumor.
Oral Administration: Temozolomide is available in oral capsule form, making it convenient for patients to take at home. The dosage and schedule of administration may vary depending on the specific treatment regimen prescribed by a healthcare provider.
Chemotherapy Side Effects: Like other chemotherapy drugs, temozolomide can cause a range of side effects, including nausea, vomiting, diarrhea, loss of appetite, fatigue, hair loss (alopecia), and increased susceptibility to infections. These side effects can vary in severity and may require supportive care or dose adjustments.
Myelosuppression: Temozolomide can suppress the bone marrow's ability to produce blood cells, leading to a decrease in white blood cells (leukopenia), red blood cells (anemia), and platelets (thrombocytopenia). This can result in an increased risk of infection, fatigue, and bleeding tendencies.
Hematologic Toxicity: Hematologic toxicity, including neutropenia (low neutrophil count) and thrombocytopenia (low platelet count), is a common side effect of temozolomide therapy. Close monitoring of blood counts is essential during treatment, and dose adjustments may be necessary to manage hematologic toxicity.
Hepatic and Renal Effects: Temozolomide may cause liver and kidney dysfunction, as evidenced by elevated liver enzymes (AST, ALT) and impaired renal function tests (creatinine, BUN). Patients with pre-existing liver or kidney disease may require dose adjustments or close monitoring during treatment.
Neurological Effects: Temozolomide can cause neurological side effects such as headache, dizziness, and fatigue. In rare cases, it may lead to seizures or exacerbate existing neurological symptoms in patients with brain tumors.
Teratogenicity: Temozolomide can cause fetal harm if administered during pregnancy and is contraindicated in pregnant women. Female patients of childbearing potential should use effective contraception during treatment and for a period after discontinuation of therapy.
Long-term Effects: Temozolomide treatment may have long-term effects on cognitive function and quality of life in survivors of brain tumors. Close monitoring and supportive care are essential to address any long-term complications or sequelae associated with treatment.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]
